Convergence Investment Partners, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 220 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 4.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Convergence Investment Partners, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$1,169,000
-35.9%
74,357
-32.9%
0.16%
-31.5%
Q1 2018$1,824,000
+13.3%
110,861
+24.4%
0.24%
+10.2%
Q4 2017$1,610,000
-30.2%
89,121
-25.5%
0.22%
-33.9%
Q3 2017$2,308,000
+75.8%
119,602
+7.5%
0.33%
+70.3%
Q2 2017$1,313,000
-13.7%
111,231
-19.9%
0.19%
-10.3%
Q1 2017$1,521,000
+95.8%
138,800
+29.7%
0.21%
+100.0%
Q4 2016$777,000107,0400.11%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,003,723$95,164,0006.41%
TANAKA CAPITAL MANAGEMENT INC 65,609$780,0003.41%
S&T BANK/PA 588,620$6,999,0001.93%
Parallel Advisors, LLC 1,405,895$16,716,0001.35%
Matarin Capital Management, LLC 623,915$7,418,0001.15%
AJ WEALTH STRATEGIES, LLC 668,020$7,943,0001.08%
Capital Impact Advisors, LLC 177,300$2,108,0000.88%
Alambic Investment Management, L.P. 29,547$351,0000.85%
OXFORD FINANCIAL GROUP, LTD. LLC 332,436$3,953,0000.79%
Spark Investment Management LLC 116,400$1,383,0000.74%
View complete list of CORCEPT THERAPEUTICS INC shareholders